article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. This hasn’t been made clear yet due in part to the fourth and final guidance session on clinical outcome assessment data yet to occur in 2023.

BioTech 144
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. In 2023, Pear Therapeutics filed for bankruptcy and Akili abandoned the prescription business model. AI’s influence also optimized drug manufacturing processes, enhancing efficiency, and reducing waste.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Accessed November 2023. Accessed November 2023.

article thumbnail

Protai Adds $12 Million to Seed Round – Bringing the Total to $20 Million – to Build an Oncology Drug Discovery Pipeline

Healthcare IT Today

With the additional funding, Protai will expand its activities to include an oncology drug discovery pipeline, initially focusing on targets with a clearly-defined novel patient population biomarker, derived from its AI proteomics platform. Originally announced March 15th, 2023

article thumbnail

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Healthcare IT Today

This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials. Originally announced October 24th, 2023 bringing new needed treatments to patients.”

article thumbnail

Pharma – 2023 Health IT Predictions

Healthcare IT Today

As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. That level of analytics sophistication is finally being realized and will go mainstream in 2023, reshaping the way that healthcare organizations leverage data and improve patient outcomes. Dr. Ofer Sharon, CEO at OncoHost.